Expertin
Dr.med.vet Clair Firth

Expertise

Veterinärmedizin: Forschungsschwerpunkte Antibiotika Einsatz in der Mastitistherapie in Milchviehbetrieben in Österreich Zusammenhänge zwischen akuten Mastitiden und Tier-, Management- und Umweltfaktoren Antibiotika Resistenz von klinischen und kommensalen Bakterienisolaten in Zusammenhang mit Mastitistherapien und antibiotischen Trockensteller Antimicrobial Stewardship/Prudent Use Programme

Verfügbar für

    Gender-Trainings
    Interviews
    Jury
    Kooperationen
    Mentoring
    Projektleitung
    Projektmitarbeit
    Vortragstätigkeiten

Beruflich

Mittleres Management

Tätigkeitsbereiche:
  • Universität

Ausbildung

Universität
Veterinärmedizin

Zusatzausbildung(en)
BSc (Hons) Animal Science (Nutztierwissenschaften) MSc Agricultural Development

Sprachen

  • Englisch
  • Deutsch
  • Französisch
Mehr Details
  • Englisch

    Schriftlich: Muttersprache / wie Muttersprache
    Konversation: Muttersprache / wie Muttersprache

  • Deutsch

    Schriftlich: Verhandlungssicher / Fließend
    Konversation: Verhandlungssicher / Fließend

  • Französisch

    Schriftlich: Grundkenntnisse
    Konversation: Grundkenntnisse

Referenzen

Auszeichnungen / Preise

2021: "Honourable mention" für einen Vortrag (PostDoc ForscherInnen) an der One Health Antimicrobial Stewardship Conference (Alberta Veterinary Medical Association, Canada)

Nutztierpreis 2019 der Gesellschaft der Freunde der Veterinärmedizinische Universität Wien

2019: Poster Preis der International Dairy Federation (IDF) Mastitis Conference (Kopenhagen, Dänemark)

2017 Short-Term-Mission Stipendium von der Med-Vet-Net Association

Publikationen

2022
** Firth, CL; Fuchs, R; Fuchs, K (2022): National Monitoring of Veterinary-Dispensed Antimicrobials for Use on Pig Farms in Austria: 2015–2020. Antibiotics. 2022; 11(2):216

** Firth, CL; Käsbohrer, A; Pless, P; Koeberl-Jelovcan, S; Obritzhauser, W (2022): Analysis of Antimicrobial Use and the Presence of Antimicrobial-Resistant Bacteria on Austrian Dairy Farms— A Pilot Study. Antibiotics. 2022; 11(2):124
  

** Suntinger, M; Fuerst-Waltl, B; Obritzhauser, W; Firth, CL; Köck, A; Egger-Danner, C (2022): Usability of bacteriological milk analyses for genetic improvement of udder health in Austrian Fleckvieh cows. J Dairy Sci. 2022; S0022-0302(22)00180-1
 

2021

** Firth, CLL; Kremer, K; Werner, T; Käsbohrer, A (2021): The Effects of Feeding Waste Milk Containing Antimicrobial Residues on Dairy Calf Health. Pathogens. 2021; 10(2):112
  

Sohm, C; Firth, CL; Wittek, T; Steinparzer, R; Desvars-Larrive, A (2021): Das LORN Projekt - Machen Sie mit! Leptospirose in Niederösterreich. Klauentierpraxis 2021; 29(4): 174-175.

 

2020
** León, B; Käsbohrer, A; Hutter, SE; Baldi, M; Firth, CL; Romero-Zúñiga, JJ; Jiménez, C (2020): National Seroprevalence and Risk Factors for Eastern Equine Encephalitis and Venezuelan Equine Encephalitis in Costa Rica. J Equine Vet Sci. 2020; 92:103140
  

** Sanders, P; Vanderhaeghen, W; Fertner, M; Fuchs, K; Obritzhauser, W; Agunos, A; Carson, C; Borck Høg, B; Dalhoff Andersen, V; Chauvin, C; Hémonic, A; Käsbohrer, A; Merle, R; Alborali, GL; Scali, F; Firth, CL, [and 14 others] (2020): Monitoring of Farm-Level Antimicrobial Use to Guide Stewardship: Overview of Existing Systems and Analysis of Key Components and Processes. Front Vet Sci. 2020; 7:540
  

Firth, CL; Egger-Danner, C; Fuchs, K; Käsbohrer, A; Obritzhauser, W (2020): Antibiotikaeinsatz bei Mastitiden in österreichischen Milchviehbetrieben – Ergebnisse des ADDA-Projektes. Klauentierpraxis 2020; 28: 137-143.

2019
** Firth, CL; Käsbohrer, A; Egger-Danner, C; Fuchs, K; Pinior, B; Roch, FF; Obritzhauser, W (2019): Comparison of Defined Course Doses (DCDvet) for Blanket and Selective Antimicrobial Dry Cow Therapy on Conventional and Organic Farms. Animals. 2019; 9(10):707
    

** Firth, CL; Laubichler, C; Schleicher, C; Fuchs, K; Käsbohrer, A; Egger-Danner, C; Köfer, J; Obritzhauser, W (2019): Relationship between the probability of veterinary-diagnosed bovine mastitis occurring and farm management risk factors on small dairy farms in Austria. J Dairy Sci. 2019; 102(5):4452-4463
  

** Richter, V; Kattwinkel, E; Firth, CL; Marschik, T; Dangelmaier, M; Trauffler, M; Obritzhauser, W; Baumgartner, W; Käsbohrer, A; Pinior, B (2019): Mapping the global prevalence of bovine viral diarrhoea virus infection and its associated mitigation programmes. Vet Rec. 2019; 184(23):711
   

2018
** Pinior, B; Firth, CL; Loitsch, A; Stockreiter, S; Hutter, S; Richter, V; Lebl, K; Schwermer, H; Käsbohrer, A (2018): Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007-2016). Vet Rec. 2018; 182(9):257
    

** Schabauer, A; Pinior, B; Gruber, CM; Firth, CL; Käsbohrer, A; Wagner, M; Rychli, K; Obritzhauser, W (2018): The relationship between clinical signs and microbiological species, spa type, and antimicrobial resistance in bovine mastitis cases in Austria. Vet Microbiol. 2018; 227:52-60
   

** Scharnböck, B; Roch, FF; Richter, V; Funke, C; Firth, CL; Obritzhauser, W; Baumgartner, W; Käsbohrer, A; Pinior, B (2018): A meta-analysis of bovine viral diarrhoea virus (BVDV) prevalences in the global cattle population. Sci Rep. 2018; 8(1):14420 

2017
** Firth, CL; Käsbohrer, A; Schleicher, C; Fuchs, K; Egger-Danner, C; Mayerhofer, M; Schobesberger, H; Köfer, J; Obritzhauser, W (2017): Antimicrobial consumption on Austrian dairy farms: an observational study of udder disease treatments based on veterinary medication records. PeerJ. 2017; 5:e4072
     

** Pinior, B; Firth, CL (2017): The economics of bovine viral diarrhoea eradication. Vet Rec. 2017; 181(11):300
   

** Pinior, B; Firth, CL; Richter, V; Lebl, K; Trauffler, M; Dzieciol, M; Hutter, SE; Burgstaller, J; Obritzhauser, W; Winter, P; Käsbohrer, A (2017): A systematic review of financial and economic assessments of bovine viral diarrhea virus (BVDV) prevention and mitigation activities worldwide. Prev Vet Med. 2017; 137(Pt A):77-92
   

2016
** Hutter, SE; Brugger, K; Sancho Vargas, VH; González, R; Aguilar, O; León, B; Tichy, A; Firth, CL; Rubel, F (2016): Rabies in Costa Rica: Documentation of the Surveillance Program and the Endemic Situation from 1985 to 2014. Vector Borne Zoonotic Dis. 2016; 16(5):334-341
    

** Raith, J; Trauffler, M; Firth, CL; Lebl, K; Schleicher, C; Köfer, J (2016): Influence of porcine circovirus type 2 vaccination on the level of antimicrobial consumption on 65 Austrian pig farms. Vet Rec. 2016; 178(20):504
 

2015
** Altorjay, Á; Szabó, É; Boda, Z; Kramer, L; Ngo, LY; Engl, W; Firth, CL; Ahlstrom, ER; Gelmont, DM; Pabinger, I (2015): An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal. Thromb Res. 2015; 135(3):485-491
  

** Firth, CL; Möstl, K (2015): A survey of feline leukaemia virus antigenaemia among cats in eastern Austria: a retrospective analysis of serum samples routinely tested between 1996 and 2011. JFMS Open Rep. 2017; 1(2):2055116915598336
  

** Pinior, B; Lebl, K; Firth, C; Rubel, F; Fuchs, R; Stockreiter, S; Loitsch, A; Köfer, J (2015): Cost analysis of bluetongue virus serotype 8 surveillance and vaccination programmes in Austria from 2005 to 2013. Vet J. 2015; 206(2):154-160

Firth, C (2015): Antibiotikareduktion in der Mastitistherapie. Kompendium Nutztiermedizin 5-11.

2013
** Wressnigg, N; Pöllabauer, EM; Aichinger, G; Portsmouth, D; Löw-Baselli, A; Fritsch, S; Livey, I; Crowe, BA; Schwendinger, M; Brühl, P; Pilz, A; Dvorak, T; Singer, J; Firth, C; Luft, B [and 9 others] (2013): Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. Lancet Infect Dis (13), 8 680-689.
  

2011
** Loew-Baselli, A; Poellabauer, EM; Pavlova, BG; Fritsch, S; Firth, C; Petermann, R; Barrett, PN; Ehrlich, HJ (2011): Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme. Vaccine. 2011; 29(43):7307-7319
  

2010

** Pöllabauer, EM; Fritsch, S; Pavlova, BG; Löw-Baselli, A; Firth, C; Koska, M; Maritsch, F; Barrett, PN; Ehrlich, HJ (2010): Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine. Vaccine. 2010; 28(29):4558-4565
  

** Pöllabauer, EM; Pavlova, BG; Löw-Baselli, A; Fritsch, S; Prymula, R; Angermayr, R; Draxler, W; Firth, C; Bosman, J; Valenta, B; Harmacek, P; Maritsch, F; Barrett, PN; Ehrlich, HJ (2010): Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine. 2010; 28(29):4680-4685